Australia Stock Exchange release from NOXOPHARM : DARRT-2 Trial Commences in the U.S.
03/11/2021 21:33
Australia Stock Exchange release from NOXOPHARM NOX.AX : DARRT-2 Trial Commences in the U.S
Recent news on Noxopharm
See all newsAustralia's Noxopharm hits three-month low on discounted placement
Brief: Noxopharm Receives Commitments For Placement
Brief: Noxopharm Requests Trading Halt Pending Material Capital Raising Announcement
Brief: Noxopharm Announces SOF-SKN Manufacturing Begins To Ensure Clinical Trial Readiness
Australia's Noxopharm rises as novel cancer therapy shows potential